跳至主要内容
临床试验/CTRI/2023/03/050179
CTRI/2023/03/050179进行中(未招募)3 期

Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery Trial - DEPOSITIO

Population Health Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.= 18 years of age
  • 2.Undergoing a cardiac surgical procedure (i.e. isolated coronary artery bypass graft (CABG), isolated single cardiac valve surgery or a combination of both or isolated ascending aorta replacement) with the use of cardiopulmonary bypass (CPB) and median sternotomy.
  • 3.Provide written informed consent

排除标准

  • 1.Allergy to tranexamic acid
  • 2.Undergoing minimally invasive surgery
  • 3.Fulfill any of the following transfusion risk factors (A-D):
  • A. Emergency surgery B. History of bleeding disorder C. Inherited thromboembolic or hemorrhagic disease D. Infective endocarditis (active)
  • 4.History of previous cardiac surgery
  • 5.Estimated glomerular filtration rate <30 mL/min (CKD-EPI equation) or on dialysis
  • 6.Pre-operative hemoglobin > 170 g/L or <110 g/L
  • 7.Pre-operative thrombocytopenia ( <50,000 platelets per µL)
  • 8.Expected circulatory arrest
  • 9.Pregnancy or breast feeding
  • 10.Previously enrolled in the DEPOSITION trial
  • 11.Refusal of blood products
  • 12.Pericardiectomy

研究者

相似试验